Functionalized branched polymers: promising immunomodulatory tools for the treatment of cancer and immune disorders
- 19 June 2019
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Mater. Horiz.
- Vol. 6 (10), 1956-1973
- https://doi.org/10.1039/c9mh00628a
Abstract
Well-defined synthetic branched nanostructures form an emerging subclass of macromolecular structures whose 3D structure and multivalency offer unique opportunities for fine-tuning internalization and cellular targeting. Dendrimers possess a well-defined 3D-globular backbone with highly versatile functional surface groups and exhibit a range of chemical and biological properties. Branched polymers present unique opportunities for the targeted delivery of diverse bioactive molecules (including targeting ligands, imaging probes, and drugs) via conjugation to multiple sites within the structure. The inherent versatility and multifunctionality of these architectures make them potentially useful for the modulation of multiple immune-related pathways for the treatment of a wide range of diseases and disorders, including cancer and human immunodeficiency virus infection. Herein, we describe the key components of the immune system whose targeting can help overcome immune-related disorders and discuss branched polymers (including dendrimers) as promising delivery systems with unique immunomodulatory properties against cancer and infectious diseases.Keywords
Funding Information
- H2020 European Research Council (ERC-MyNano, ERC-Polyimmune, ERC-CoG-2014-648831, ERC-PoC-2018-825798)
- Fundação para a Ciência e a Tecnologia (SFRH/BPD/94111/2013, SFRH/BD/87591/2012, PD/BD/113959/2015, SFRH/BD/87869/2012, UTAP-ICDT/DTP-FTO/0016/2014, SAICTPAC/0019/2015, UID/DTP/04138/2019)
- Ministerio de Ciencia e Innovación (SAF2016-80427-R)
- University of Hertfordshire
This publication has 138 references indexed in Scilit:
- Dendrimers as Potential Therapeutic Tools in HIV InhibitionMolecules, 2013
- Surface modification of PAMAM dendrimer improves its biocompatibilityNanomedicine: Nanotechnology, Biology and Medicine, 2012
- Dendritic Cells The Tumor Microenvironment and the Challenges for an Effective Antitumor VaccinationJournal of Biomedicine and Biotechnology, 2012
- In vivo modulation of dendritic cells by engineered materials: Towards new cancer vaccinesNano Today, 2011
- Multifunctional Triblock Nanocarrier (PAMAM-PEG-PLL) for the Efficient Intracellular siRNA Delivery and Gene SilencingACS Nano, 2011
- Dendrimer−Drug Conjugates for Tailored Intracellular Drug Release Based on Glutathione LevelsBioconjugate Chemistry, 2008
- Enhanced Mucosal Immunoglobulin A Response and Solid Protection against Foot-and-Mouth Disease Virus Challenge Induced by a Novel Dendrimeric PeptideJournal of Virology, 2008
- Dendrimer based non-competitive fluoroimmunoassay for analysis of cortisolReactive and Functional Polymers, 2008
- Dendritic cells heterogeneity and its role in cancer immunityJournal of Cancer Research and Therapeutics, 2006
- Molecular Size Distribution in Three Dimensional Polymers. I. Gelation1Journal of the American Chemical Society, 1941